Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BioNexus Gene Lab Corp. (BGLC) vs Crown Electrokinetics Corp. (CRKN)

BioNexus Gene Lab Corp. and Crown Electrokinetics Corp. are both Specialty Chemicals companies. Crown Electrokinetics Corp. is the larger, with a market value of $5.8M against $4.3M — 1.3× the size. Crown Electrokinetics Corp. grew revenue faster over the last twelve months: 2,509.7% against −67.3%. BioNexus Gene Lab Corp. has the higher net margin (−82.4% vs −171.0%) and the higher return on invested capital (−37.2% vs −135.0%). Across the 18 metrics below, BioNexus Gene Lab Corp. leads on 12 and Crown Electrokinetics Corp. on 6.

Valuation

Metric BGLC CRKN Specialty Chemicals median
P/E n/m n/m 24.83
P/S 1.06 0.00 1.46
P/B 0.43 0.00 1.76
Price to free cash flow n/m n/m 19.84
EV/EBITDA 0.07 0.79 13.18
EV/Sales (0.05) (1.00) 1.84
Earnings yield (91.97%) 22,602,570.00% 2.11%
Free cash flow yield (25.78%) (204,824.82%) 2.29%

Profitability

Metric BGLC CRKN Specialty Chemicals median
Gross margin 12.34% (3.25%) 29.23%
Operating margin (79.62%) (139.14%) 3.63%
Net margin (82.36%) (170.97%) 2.89%
Free cash flow margin (27.30%) (157.22%) 3.78%
Return on equity (33.66%) (195.09%) 3.62%
Return on assets (28.38%) (142.30%) 0.35%
Return on invested capital (37.16%) (134.95%) 2.75%

Growth

Metric BGLC CRKN Specialty Chemicals median
Revenue growth (TTM) (67.27%) 2,509.70% 4.51%
EPS growth (last fiscal year) (79.49%) (414.51%) —
Revenue growth, 5-year CAGR (8.20%) — 6.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGLC CRKN Specialty Chemicals median
Debt to equity 0.01 0.02 0.54
Current ratio 6.08 5.11 1.94
Net debt to EBITDA 1.49 0.62 2.03

Dividend

Metric BGLC CRKN Specialty Chemicals median
Dividend yield — — 1.69%
Payout ratio — 0.00 0.25

Size

Metric BGLC CRKN Specialty Chemicals median
Market cap 4.34m 5.80m 2.43b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack